Company Encyclopedia
View More
name
Diversified Healthcare Trust
DHC.US
DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of September 30, 2025, DHC’s approximately $6.7 billion portfolio included 335 properties in 34 states and Washington, D.C., with more than 26,000 senior living units, approximately 6.9 million square feet of medical office and life science properties and occupied by approximately 420 tenants. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S.
1.412 T
DHC.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
D
Equity Real Estate Investment Trusts (REITs)Industry
Industry Ranking127/164
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-18.84%E
    • Profit Margin-22.90%E
    • Gross Margin15.99%D
  • Growth ScoreC
    • Revenue YoY4.10%C
    • Net Profit YoY8.63%C
    • Total Assets YoY-11.38%E
    • Net Assets YoY-17.56%E
  • Cash ScoreD
    • Cash Flow Margin-436.77%E
    • OCF YoY4.10%C
  • Operating ScoreD
    • Turnover0.31D
  • Debt ScoreD
    • Gearing Ratio63.95%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Diversified Healthcare Trust Reports Q3 2025 Results

    Diversified Healthcare Trust (DHC) reported its Q3 2025 financial results, showcasing a portfolio valued at approximately $6.7 billion. The REIT specializes in healthcare properties, including 335 properties across 34 states and Washington, D.C., with over 26,000 senior living units and 6.9 million square feet of medical office and life science properties. DHC emphasizes diversification and strategic growth, aiming to enhance shareholder value with the expertise of The RMR Group in the evolving healthcare real estate market.

    Tip Ranks·
    US
    DHC
    -0.52%
    Tip Ranks·
    US
    DHC
    -0.52%

    ON Semiconductor’s Earnings Call Highlights Growth Amid Challenges

    ON Semiconductor's earnings call highlighted strong growth in automotive, industrial, and AI segments, despite regional revenue declines and macroeconomic challenges. The company reported Q3 revenue of $1.55 billion, exceeding guidance, with a non-GAAP gross margin of 38%. Key growth areas include a 7% increase in automotive revenue and a doubling of AI revenue year-over-year. Strategic acquisitions are set to enhance its portfolio, while geographical revenue growth was noted in the Americas and Japan. However, Europe and China faced declines. The company anticipates Q4 revenue between $1.48 billion and $1.58 billion, focusing on innovation and growth.

    Tip Ranks·
    US
    ON
    +1.64%
    Tip Ranks·
    US
    ON
    +1.64%

    Diversified Healthcare Trust shares are trading lower after the company reported worse-than-expected Q3 FFO results.

    benzinga_article·
    US
    DHC
    -0.52%
    benzinga_article·
    US
    DHC
    -0.52%

    Diversified Healthcare Trust reports results for the quarter ended September 30 - Earnings Summary

    Diversified Healthcare Trust reported a quarterly adjusted loss of 68 cents per share for the quarter ended September 30, compared to a loss of 41 cents in the same quarter last year. Revenue increased by 4% to $388.71 million, exceeding analyst expectations of $382.30 million. The company reported a total loss of $164.04 million. Analyst ratings are mixed, with a current average recommendation of "hold". The median 12-month price target is $4.25, slightly below the last closing price of $4.26.

    Reuters·
    US
    DHC
    -0.52%
    Reuters·
    US
    DHC
    -0.52%

    Diversified Healthcare Trust | 10-Q: FY2025 Q3 Revenue Beats Estimate at USD 388.71 M

    LB filings·
    US
    DHC
    -0.52%
    LB filings·
    US
    DHC
    -0.52%
    © 2025 Longbridge｜Disclaimer